Literature DB >> 24355660

Sonographic and clinical features of collateral vessels at the splenic hilum in cirrhosis.

H Maruyama1, H Kamezaki2, T Kondo2, T Sekimoto2, M Takahashi2, O Yokosuka2.   

Abstract

AIM: To examine the sonographic features of shunt vessels derived from the splenic vein at splenic hilum (SS), and explore the relationship between the SS pattern and clinical presentations.
MATERIALS AND METHODS: This prospective study in cirrhotic patients consisted of study I (n = 15), which compared the anatomical features of SS at ultrasonography versus angiography, and study II (n = 233), which examined the incidence/haemodynamics of SS and SS-related presentations.
RESULTS: Study I showed that SS1 (running toward the upper pole of the spleen) corresponded to short gastric veins, and SS2 (running toward the lower pole of the spleen) corresponded to splenorenal/retroperitoneal shunts. In study II, SS were detected in 47.6% of patients (111/233), SS1 in 77.5% (86/111), SS2 in 17.1% (19/111), and SS3 (both SS1 and SS2) in 5.4% (6/111). The incidence of gastric cardia varices was significantly higher in patients with SS2 (6/19) than in those with SS1 (8/86, p = 0.0097), whereas the incidence of gastric fundal varices was significantly higher in patients with SS1 (44/86) than in those with SS2 (1/19, p = 0.00025) or SS3 (0/6, p = 0.015). There was no difference in the incidence of oesophageal varices among the three SS groups. The Child-Pugh score and grade of ascites was significantly worse in patients with SS3 than in those with SS1 (p < 0.0001, p = 0.0009). Hepatic encephalopathy grade was significantly worse in patients with SS2 (p = 0.0047) or SS3 (p < 0.0001) compared to SS1.
CONCLUSION: The SS pattern facilitates estimation of the possible manifestations, indicating the direction of clinical management of cirrhosis patients. Potential poor liver function is noted in patients with SS3.
Copyright © 2013 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 24355660     DOI: 10.1016/j.crad.2013.11.001

Source DB:  PubMed          Journal:  Clin Radiol        ISSN: 0009-9260            Impact factor:   2.350


  7 in total

1.  Hemodynamic effect of the left gastric artery on esophageal varices in patients with cirrhosis.

Authors:  Soichiro Kiyono; Hitoshi Maruyama; Takayuki Kondo; Tadashi Sekimoto; Taro Shimada; Masanori Takahashi; Osamu Yokosuka
Journal:  J Gastroenterol       Date:  2016-01-18       Impact factor: 7.527

Review 2.  Collaterals in portal hypertension: anatomy and clinical relevance.

Authors:  Hitoshi Maruyama; Shuichiro Shiina
Journal:  Quant Imaging Med Surg       Date:  2021-08

3.  Differential Clinical Impact of Ascites in Cirrhosis and Idiopathic Portal Hypertension.

Authors:  Hitoshi Maruyama; Takayuki Kondo; Tadashi Sekimoto; Osamu Yokosuka
Journal:  Medicine (Baltimore)       Date:  2015-07       Impact factor: 1.889

Review 4.  Ultrasonography for Noninvasive Assessment of Portal Hypertension.

Authors:  Hitoshi Maruyama; Osamu Yokosuka
Journal:  Gut Liver       Date:  2017-07-15       Impact factor: 4.519

5.  Interrelationship between insulin resistance and portal haemodynamic abnormality in cirrhosis.

Authors:  Hitoshi Maruyama; Kazufumi Kobayashi; Soichiro Kiyono; Osamu Yokosuka
Journal:  Int J Med Sci       Date:  2017-02-23       Impact factor: 3.738

6.  Left gastric vein-based noninvasive test for esophageal varices: a same-day comparison of portal hemodynamic assessment with endoscopic appearance.

Authors:  Hitoshi Maruyama; Kazufumi Kobayashi; Soichiro Kiyono; Sadahisa Ogasawara; Yoshihiko Ooka; Eiichiro Suzuki; Tetsuhiro Chiba; Naoya Kato
Journal:  Clin Transl Gastroenterol       Date:  2018-05-25       Impact factor: 4.488

7.  Incidence and hemodynamic feature of risky esophageal varices with lower hepatic venous pressure gradient.

Authors:  Hitoshi Maruyama; Kazufumi Kobayashi; Soichiro Kiyono; Sadahisa Ogasawara; Yoshihiko Ooka; Eiichiro Suzuki; Tetsuhiro Chiba; Naoya Kato; Yasuyuki Komiyama; Masashi Takawa; Hiroaki Nagamatsu; Shuichiro Shiina
Journal:  Int J Med Sci       Date:  2019-11-09       Impact factor: 3.738

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.